Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study

被引:0
|
作者
Lorenzo Iughetti
Gianluca Tornese
Maria Elisabeth Street
Flavia Napoli
Claudia Giavoli
Franco Antoniazzi
Stefano Stagi
Caterina Luongo
Sara Azzolini
Letizia Ragusa
Gianni Bona
Clara Zecchino
Tommaso Aversa
Luca Persani
Laura Guazzarotti
Emiliano Zecchi
Alberto Pietropoli
Stefano Zucchini
机构
[1] University of Modena and Reggio Emilia,Pediatric Unit, Department of Medical and Surgical Sciences for Mother, Children and Adults
[2] Institute for Maternal and Child Health IRCCS Burlo Garofolo,Pediatric Unit
[3] Department of Paediatrics- Arcispedale S. Maria Nuova-IRCCS,Endocrinology and Metabolic Diseases Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
[4] Istituto Giannina Gaslini,Pediatric Unit, Policlinico Giambattista Rossi
[5] Università degli Studi di Milano,Health Science Department, Anna Meyer Children’s University Hospital
[6] University of Verona,Department of Woman, Child and General and Specialized Surgery
[7] University of Florence,Pediatric Endocrinology Unit, Department of Woman’s and Child’s Health
[8] Seconda Università degli Studi di Napoli,Division of Paediatrics
[9] University Hospital of Padua,Department of Sciences and Pediatric Surgery
[10] UOC Pediatria,Department of Human Pathology of Adulthood and Childhood
[11] I.R.C.S.S. Oasi Maria SS,Department of Clinical Sciences and Community Health
[12] Azienda Ospedaliero-Universitaria Maggiore della Carità,Department of Paediatrics, Paediatric Endocrinology Unit
[13] University of Bari “A. Moro”,Unit of Pediatric Endocrinology
[14] University of Messina,undefined
[15] University of Milan,undefined
[16] Division of Endocrine and Metabolic Diseases,undefined
[17] IRCCS Istituto Auxologico Italiano,undefined
[18] University of Milan,undefined
[19] Sandoz S.p.A,undefined
[20] Hexal AG,undefined
[21] S.Orsola-Malpighi Hospital,undefined
关键词
Adolescents; Children; Infants; Omnitrope®; Paediatric; Recombinant human growth hormone;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope® in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study
    Romer, T.
    Saenger, P.
    Peter, F.
    Walczak, M.
    Le Bouc, Y.
    Khan-Boluki, J.
    Berghout, A.
    HORMONE RESEARCH, 2009, 72 (06) : 359 - 369
  • [32] Long-Term Safety of Recombinant Human Growth Hormone in Children
    Bell, J.
    Parker, K. L.
    Swinford, R. D.
    Hoffman, A. R.
    Maneatis, T.
    Lippe, B.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 167 - 177
  • [33] Safety and effectiveness of Omnitrope® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data
    Philippe Backeljauw
    Shankar Kanumakala
    Sandro Loche
    Karl Otfried Schwab
    Bradley S. Miller
    Richard Levy
    Kenneth McCormick
    Hichem Zouater
    Markus Zabransky
    Kim Campbell
    European Journal of Pediatrics, 2022, 181 : 2367 - 2378
  • [34] Growth hormone treatment in children with Prader-Willi syndrome: safety and effectiveness data from the PATRO Children study
    Laemmer, Constanze
    Backeljauw, Philippe
    Tauber, Maite
    Kanumakala, Shankar
    Loche, Sandro
    Schwab, Karl Otfried
    Pfaeffle, Roland
    Hoeybye, Charlotte
    Lundberg, Elena
    Dahlgren, Jovanna
    Ek, Anna E.
    Battelino, Tadej
    Kristroem, Berit
    Esmael, Altaher
    Zabransky, Markus
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2024, 15
  • [35] Long-Term Safety and Effectiveness of Growth Hormone Treatment in Pediatric Patients with Growth Hormone Deficiency: Interim Results of LG Growth Study
    Chung, Sochung
    Hwang, Il Tae
    Rhie, Young Jun
    Kim, Jae Hyun
    Chae, Hyun-Wook
    Choi, Jin Ho
    Yoo, Jae-ho
    Shin, Choong Ho
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 525 - 525
  • [36] Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
    Deal, Cheri
    Steelman, Joel
    Vlachopapadopoulou, Elpis
    Stawerska, Renata
    Silverman, Lawrence A.
    Phillip, Moshe
    Kim, Ho-Seong
    Ko, Cheol Woo
    Malievskiy, Oleg
    Cara, Jose F.
    Roland, Carl L.
    Taylor, Carrie Turich
    Valluri, Srinivas Rao
    Wajnrajch, Michael P.
    Pastrak, Aleksandra
    Miller, Bradley S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (07): : E2717 - E2728
  • [37] Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study
    Backeljauw, Philippe
    Kanumakala, Shankar
    Loche, Sandro
    Schwab, Karl Otfried
    Pfaffle, Roland Werner
    Hoybye, Charlotte
    Lundberg, Elena
    Battelino, Tadej
    Kristrom, Berit
    Giemza, Tomasz
    Zouater, Hichem
    HORMONE RESEARCH IN PAEDIATRICS, 2021, : 133 - 143
  • [38] Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study
    M. Cappa
    L. Iughetti
    S. Loche
    M. Maghnie
    A. Vottero
    Journal of Endocrinological Investigation, 2016, 39 : 667 - 677
  • [39] Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study
    Cappa, M.
    Iughetti, L.
    Loche, S.
    Maghnie, M.
    Vottero, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (06) : 667 - 677
  • [40] Long-Term Efficacy and Safety of Recombinant Human Growth Hormone in Children Born Small for Gestational Age
    Wu, Wei
    Gong, Chunxiu
    Li, Yuchuan
    Hu, Yuhua
    Gong, Haihong
    Fu, Junfen
    Huang, Ke
    Li, Pin
    Luo, Xiaoping
    HORMONE AND METABOLIC RESEARCH, 2023, 55 (09) : 599 - 609